AKT1 and bronchiolitis obliterans syndrome: Our Western blotting analysis showed that compared with the Con group, the BO-treated group had significantly increased activation of the PI3K/AKT/mTOR signaling pathway, with gradually upregulated phosphorylated proteins of this pathway.